rubella vaccine, live

Rubella vaccine, live is a live-attenuated viral vaccine primarily derived from the Wistar Institute RA 27/3 strain of the rubella virus. It is indicated for active immunization to prevent rubella (German measles) and is critical in preventing congenital rubella syndrome in newborns when administered to women of childbearing age prior to pregnancy. The vaccine works by inducing the production of specific neutralizing antibodies and stimulating a cell-mediated immune response against the rubella virus. While available as a monovalent product (e.g., Meruvax II), it is most frequently administered as a component of combination vaccines such as MMR (measles, mumps, and rubella). Recent developments include the creation of serum-free formulations and needle-free delivery systems to improve global access and safety.

Brand names

Meruvax II

Other names

rubella virus vaccine livelive attenuated rubella vaccineRA 27/3 strain vaccine